Ligand validation:8SU1

210: PAMIDRONATE

210 is a Ligand Of Interest in 8SU1 designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
8SU1_210_A_405	97%	39%	0.065	0.981	1.57	0.85	4	-	0	0	100%	0.956
7KJ8_210_A_405	91%	35%	0.079	0.966	1.56	1.03	2	-	0	0	100%	1
4NKF_210_A_404	94%	7%	0.083	0.984	3.09	1.87	6	5	0	0	100%	1
4OGU_210_A_405	90%	8%	0.085	0.967	3.46	1.22	6	1	0	0	100%	1
4KPJ_210_A_901	90%	9%	0.108	0.99	3.01	1.49	5	4	0	0	100%	1
5ERO_210_B_804	85%	19%	0.122	0.988	2.35	1.14	2	1	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.